Estazolam: clinical applications and precautions of sedative-hypnotic drugs

Estazolam is a benzodiazepine sedative-hypnotic drug mainly used to treat insomnia, anxiety, epilepsy and other diseases. This article will focus on five aspects: pharmacological effects, indications, usage and dosage, adverse reactions and manufacturers, focusing on the importance of rational use of drugs to avoid the risk of abuse and dependence.

Pharmacological effects and indications

Estazolam achieves sedative, hypnotic and anxiolytic effects by enhancing the inhibitory effect of gamma-aminobutyric acid (GABA) in the central nervous system. Clinically, it is mainly used for: 1) short-term treatment of insomnia, especially difficulty falling asleep; 2) relieving anxiety symptoms; 3) assisting in the control of epileptic seizures. It should be noted that long-term use may lead to tolerance and dependence, and medical advice must be strictly followed.

Usage, dosage and precautions

The usual dosage for adults is 1-2 mg before going to bed. The elderly or those with liver and kidney dysfunction need to reduce the dosage. During medication, you should avoid drinking alcohol or operating machinery to prevent aggravation of central depression. It is contraindicated for pregnant women, lactating women and patients with myasthenia gravis. Sudden discontinuation of the drug may cause withdrawal reactions, so it is recommended to gradually reduce the dose.

Adverse reactions and risk warnings

Common side effects include dizziness, fatigue, dry mouth, etc., and occasionally memory loss or allergic reactions. Long-term use may affect cognitive function, and the efficacy needs to be regularly evaluated. The National Medical Products Administration clearly requires that such drugs be managed as Class II psychotropic drugs, and the prescription quantity should not exceed 7 days.

Summary and production information

Estazolam is a short-term solution for insomnia and anxiety, but the benefits need to be weighed against the risks. Major domestic manufacturers include Enhua Pharmaceutical (trade name: Shulera Diazepam), Shandong Xinyi Pharmaceutical, etc. The specific product information is as follows:

Quote sources:
1. "Chinese Pharmacopoeia" 2020 Edition Part 2
2. National Medical Products Administration’s “Guiding Principles for the Clinical Application of Psychotropic Drugs”
3. Enhua Pharmaceutical Drug Instructions (Approval Date: 2021)